Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal; ICVS/3Bs, PT Government Associated Laboratory, Braga/Guimarães, Portugal.
Int Rev Neurobiol. 2013;108:1-33. doi: 10.1016/B978-0-12-410499-0.00001-0.
Tissue and organ repair still represents a clinical challenge. Tissue engineering and regenerative medicine (TERM) is an emerging field focused on the development of alternative therapies for tissue/organ repair. This highly multidisciplinary field, in which bioengineering and medicine merge, is based on integrative approaches using scaffolds, cell populations from different sources, growth factors, nanomedicine, gene therapy, and other techniques to overcome the limitations that currently exist in the clinics. Indeed, its overall objective is to induce the formation of new functional tissues, rather than just implanting spare parts. This chapter aims at introducing the reader to the concepts and techniques of TERM. It begins by explaining how TERM have evolved and merged into TERM, followed by a short overview of some of its key aspects such as the combinations of scaffolds with cells and nanomedicine, scaffold processing, and new paradigms of the use of stem cells for tissue repair/regeneration, which ultimately could represent the future of new therapeutic approaches specifically aimed at clinical applications.
组织和器官修复仍然是一个临床挑战。组织工程和再生医学(TERM)是一个新兴领域,专注于开发组织/器官修复的替代疗法。这个高度多学科的领域,将生物工程和医学融合在一起,基于使用支架、来自不同来源的细胞群体、生长因子、纳米医学、基因治疗和其他技术的综合方法,以克服目前临床中存在的局限性。事实上,其总体目标是诱导新的功能性组织的形成,而不仅仅是植入备用零件。本章旨在向读者介绍 TERM 的概念和技术。它首先解释了 TERM 是如何发展和融合到 TERM 中的,然后简要概述了其一些关键方面,如支架与细胞和纳米医学的结合、支架处理以及用于组织修复/再生的干细胞的新范例,这些最终可能代表着针对特定临床应用的新治疗方法的未来。